challeng post-merg integr phase
post-merg reveal greater expect execut challeng
profit warn issu juli unveil post-merg integr challeng
even wors fear sell case main problem area
germani us germani one-stop-shop
strategi reportedli fulli accept custom manag state
call restructur program germani delay also
neg impact motiv sale staff us integr remain
challeng margin mix remain neg safe lock busi come
back cost last year significantli diminish year
digit cost went last year expect stay high go
forward base delay uncertainti post-merg integr
challeng seem multi-lay reduc ep estim
fy lower pt maintain sell rate
four reason cautiou stanc ebitda margin target
compani pushed-out ebitda margin target two year
doubt compani even reach follow reason lack sale
synergi would leverag asset base poor us product mix like stay
uncertainti regard post-merg cost benefit inflat impact name raw
materi wage inflat might fulli compens price hike
calcul ebitda margin fy
 expenditur remain high sale
dormakaba continu invest heavili digit project welcom
howev could creat addit pressur mid-term margin develop
compani guid cost increas sale
valuat dcf-base pt lower previous
forecast termin sale growth ebit margin
wacc unchang stock trade
discount assa abloy ev/ebtda in-lin long-term histor
averag offer lower org sale growth rate vs ebitda
trade data key metric
compani account thomson reuter ub estim metric mark ub analyst adjust appli valuat base averag share price year base
share price aug bst
report prepar ub limit analyst certif requir disclosur begin page
ub seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis
ub research thesi map guid think report
 dormakaba reach ebitda margin target fy
believ despit compani push ebitda target two year
recent forecast despit post-merg integr cost-optimis programm
place
valuat premium justifi
 dormakaba structur grow sale global
ambiti view think compani abl outgrow global
driven structur industri trend urban demograph chang increas secur need
etc plu industri consolid estim org mid-term sale compound-annual-growth-rate translat
growth plu structur growth compon
valuat premium justifi
recent profit warn mid-term guidanc push-out affirm cautiou view dormakaba
yet deliv post-merg integr germani north america particularli
seem behind schedul revis growth outlook come year half
long-term guidanc addit expect larger acquisit
next month believ lack sale synergi would leverag asset base put
mid-term ebitda margin target risk therefor retain sell rate
deliv ebitda margin last year analysi show profit would need
make bigger leap order reach ebitda fy peer group analysi show two
main peer alreadi target margin level assa abloy scale effect
three time larger dormakaba compani mid-term sale growth target pretti much
consist industri peer last year deliv guid
year merger synergi materi
believ stock valuat price expect dormakaba set reach medium-
term growth target ebitda margin
upsid downsid
compani descript dormakaba among top three compani global market secur access solut
offer comprehens portfolio product solut servic
revis estim dcf calcul
reduc sale estim due slow org growth
report guidanc growth fy
addit account fact compani could gener
sale synergi post merger acquisit last three year
also cut ebitda margin
base recent profit warn show delay
unexpect challeng post-merg integr process
figur chang ub estim
chang estim
sale growth chf
fy dormakaba trade discount main peer assa
abloy ev/ebitda roughli in-lin histor discount
price-to-earnings discount assa amount given slower org sale growth rate
fy outlook vs dormakaba vs assa lower ebitda
margin profil vs believ discount justifi
discount ev/ebitda
assa in-lin
note allegion cover ub henc base factset consensu estim
revis dcf calcul yield pt old besid
downward revis year forecast becom bit
conserv long-term sale growth margin outlook due lack
sale synergi far push-out target mid-term ebitda margin
lower forecast termin
assumpt drive dcf
termin valu henc cut sale growth rate
vs assa long-term guidanc lower termin ebit margin
vs long-term histor averag termin
wacc assumpt remain unchang
sale
sale
capital-expenditure
sale
defer tax sale
capital-expenditure sale
depreci capital-expenditure
nwc sale
discount free cash flow
number share million
valu per share chf
upsid downsid
doka trade
august
risk current share price skew downsid
doka trade august
upsid scenario upsid scenario assum medium-
region support new innov product well sale synergi
dormakaba merger recent acquisit addit assum
dormakaba beat medium-term target reach ebitda margin base
calcul dcf fair valu per share
base case assum org sale growth ebitda
margin fy expect target merger cost synergi
larg reap expect sale synergi kick
base medium-term lc sale growth ebitda margin close
deriv price target per share
downsid scenario end-market growth could slow back
weaken macro environ especi europ account
sale slowdown construct sector especi commerci segment
increas price competit addit merger bring synergi
expect factor medium-term organ sale growth
ebitda margin would suggest dcf fair valu per share
dormakaba among top three compani global
market secur access solut offer
comprehens portfolio product solut servic
secur build access product rang
mechan electron lock system physic access
automat door system door hing fit
dormakaba estim address access control
market worth accord estim
build access industri typic grow percentag
point expect mechan lock market
grow per year electromechan
market forecast post higher growth rate
mechan lock market driven strong construct
activ emerg market wherea market growth
matur area us europ mainli stem
electron access control system
revenu region
rest
revenu segment
profit tax
profit tax
net chang work capit
net cash flow
flow inc /dec net debt
balanc sheet inc /dec net debt
compani account ub estim ub metric use report figur adjust ub ep ub dilut calcul use ub net incom ad back depreci
buy minor
revenu divis chfm
ebit ub divis chfm
compani account ub estim ub metric use report figur adjust ub analyst
valuat method risk statement
price target dcf-base
dormakaba lock sale go exist build cyclic
rel low nevertheless major chang construct activ could affect
earn apart overal econom activ risk invest case
includ potenti underestim impact oper leverag failur
adequ forecast degre cyclic busi usd/chf
exchang rate experienc greater declin anticip merger
kaba dorma could pose integr execut risk
oper point view depend key personnel licenc
patent combin depend technolog expertis short
life cycl electron product pose intern risk compani
